|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 3082857 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14821592.4 |
| Date of filing the European patent application | 2014-12-17 | |
| (97) | Date of publication of the European application | 2016-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/078233 |
| Date | 2014-12-17 |
| (87) | Number | WO 2015/091655 |
| Date | 2015-06-25 |
| (30) | Number | Date | Country code |
| 13198753 | 2013-12-20 | EP | |
| 14158331 | 2014-03-07 | EP |
| (72) |
KLEIN, Christian, CH
MUELLER, Philipp, DE
THOMAS, Markus, DE
ZIPPELIUS, Alfred, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacher Strasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST |
| COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST |